Over Rs. 6 lakhs sanitizers, masks and PPE kits seized by Maharashtra FDA

The Maharashtra FDA has seized sanitizers, mask and PPE kits worth Rs. 6,14,000 lakhs on the basis of 912 inspections in one week.

On 7th May, 2020, Raid was carried out on the basis of secret information at the premises of Vinayak Gaikwad situated at Nashik. A firm was involved in manufacturing and prodcution of sanitizers and hand wash without a valid licence. The seized material included sanitizers, hand wash, empty bottles, caps, printed labels and manufacturing utensils. The team of Maharashtra FDA officials which raided comprised drug inspector (DI), intelligence branch (IB), Nashik, with DIs More and Deshmukh led by Joint Commissioner (JC) Nashik and Sunil Bhardwaj JC Vigilance under the guidance of Maharashtra FDA Commissioner Arun Unhale.

The state drug regulator solved around 11 cases of non-compliance to Essential Commodities (EC) Order and Drugs and Cosmetics (D&C) Act based on 58 secret calls at Toll free number 1800222365 and 022 26592362/26592263/26592365. The state regulator had also seized stock worth Rs. 1.80 crore hand sanitisers and masks based on 10,339 inspections over the past two weeks.

  • Related Posts

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre